Clincosm LogoSign in Get a demo

advanced solid tumor

Showing NaN - NaN of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors Trial in United States (MRTX1719)

Recruiting
  • Mesothelioma
  • +5 more
  • Denver, Colorado
  • +5 more
Aug 8, 2022

Advanced Cancer, Advanced Solid Tumor, Cancer Trial in Austin, Houston, Fairfax (BIO-106, Pembrolizumab)

Recruiting
  • Advanced Cancer
  • +3 more
  • Austin, Texas
  • +2 more
Jul 15, 2022

Advanced Solid Tumor Trial in United States (IMGC936)

Recruiting
  • Advanced Solid Tumor
  • La Jolla, California
  • +6 more
Jun 30, 2022

Advanced Solid Tumor Trial in New York, Houston, Salt Lake City (RP-6306 (oral PKMYT1 inhibitor))

Recruiting
  • Advanced Solid Tumor
  • RP-6306 (oral PKMYT1 inhibitor)
  • New York, New York
  • +2 more
Jun 21, 2022

ER+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer Trial in United States (BLU-222, Carboplatin, Ribociclib)

Recruiting
  • ER+ Breast Cancer
  • +8 more
  • Sarasota, Florida
  • +3 more
Jun 8, 2022

Solid Tumor, Adult, Advanced Solid Tumor, Metastatic Solid Tumor Trial in United Kingdom, United States (Etigilimab dosing,

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • Phoenix, Arizona
  • +15 more
Jun 6, 2022

Low-grade Glioma, Advanced Solid Tumor Trial in Worldwide (DAY101)

Recruiting
  • Low-grade Glioma
  • Advanced Solid Tumor
  • San Francisco, California
  • +35 more
May 25, 2022

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Boston, Massachusetts
  • +4 more
May 25, 2022

Advanced Solid Tumor Trial in France, Spain, United States (PM14)

Recruiting
  • Advanced Solid Tumor
  • Boston, Massachusetts
  • +8 more
May 23, 2022

Advanced Solid Tumor Trial in Canada, Denmark, United States (RP-6306, RP-3500)

Recruiting
  • Advanced Solid Tumor
  • New Haven, Connecticut
  • +11 more
Apr 25, 2022

Advanced Solid Tumor, Non Hodgkin Lymphoma, Acute Myeloid Leukemia Trial in United States (BTX-1188)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Duarte, California
  • +3 more
Apr 18, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

Recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Irvine, California
  • +15 more
Mar 9, 2022

Advanced Solid Tumor, Advanced Cancer, Triple Negative Breast Cancer Trial in Nashville, Houston, San Antonio (NBE-002)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Nashville, Tennessee
  • +2 more
Mar 3, 2022

Advanced Solid Tumor Trial in Houston, San Antonio (MRTX849, Palbociclib)

Recruiting
  • Advanced Solid Tumor
  • Houston, Texas
  • +1 more
Feb 18, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Advanced Solid Tumor Trial in Whittier, New York, Houston (YL-15293)

Recruiting
  • Advanced Solid Tumor
  • Whittier, California
  • +2 more
Nov 11, 2021

Advanced Solid Tumor Trial in Australia, New Zealand, United States (BGB-15025, Tislelizumab)

Recruiting
  • Advanced Solid Tumor
  • New York, New York
  • +5 more
Nov 2, 2021

Advanced Solid Tumor Trial in Portland, Houston (NB004 tablets)

Recruiting
  • Advanced Solid Tumor
  • NB004 tablets
  • Portland, Oregon
  • +1 more
Oct 14, 2021

Long-term, Non-interventional, Observational Study Following

Recruiting
  • Advanced Solid Tumor
  • +17 more
  • Allogeneic natural killer (NK) cell
  • San Diego, California
  • +3 more
Oct 15, 2021

Solid Tumor, Adult, Advanced Solid Tumor, Advanced Cancer Trial in United States (MPT-0118, MPT-0118 + pembrolizumab)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • Santa Monica, California
  • +4 more
Sep 15, 2021

Advanced Solid Tumor, NSCLC Trial in Taiwan, United States (NM21-1480)

Recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancer
  • NM21-1480
  • Pittsburgh, Pennsylvania
  • +3 more
May 18, 2021

Advanced Solid Tumor, Lymphoma Trial in United States (Milademetan)

Completed
  • Advanced Solid Tumor
  • Lymphoma
  • Detroit, Michigan
  • +4 more
Dec 4, 2020

Advanced Solid Tumor Trial in United Kingdom, United States (M6620, Gemcitabine, Cisplatin)

Completed
  • Advanced Solid Tumor
  • Phoenix, Arizona
  • +30 more
Mar 31, 2020

Advanced Solid Tumor Trial in United States (VX-984 120 mg + PLD 40 mg/m^2, VX-984 240 mg + PLD 40 mg/m^2, VX-984 480 mg + PLD

Completed
Has Results
  • Advanced Solid Tumor
  • VX-984 120 mg + PLD 40 mg/m^2
  • +3 more
  • Scottsdale, Arizona
  • +4 more
Jul 29, 2019

Advanced Solid Tumor Trial in Los Angeles, Rockland, Houston (Pimasertib, Temsirolimus)

Terminated
Has Results
  • Advanced Solid Tumor
  • Los Angeles, California
  • +2 more
Oct 25, 2017